[DPHARMA] Change In Substantial Shareholder's Shareholding - EMPLOYEES PROVIDENT FUND BOARD on 21-Nov-2024 | I3investor

[DPHARMA] Change In Substantial Shareholder's Shareholding - EMPLOYEES PROVIDENT FUND BOARD on 21-Nov-2024

Stock

[DPHARMA]: DUOPHARMA BIOTECH BERHAD

Announcement Date

21-Nov-2024

Director's Particular:

Name

EMPLOYEES PROVIDENT FUND BOARD

Details of Changes:

Currency

-

Date of Change	Type	Number of Shares
18-Nov-2024	Acquired	45,700

Registered Name

Citigroup Nominees (Tempatan) Sdn. Bhd.

Nature of Interest

Direct Interest

Nature Interest

Indirect Interest

Shares

Ordinary Shares

Reason

Acquisition of 45,700 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (EAST-ESG-EQ)

Total no of securities after change:

Direct (units)

0

Direct (%)

0.00

Indirect (units)

82,947,711

Indirect (%)

8.62

Total (units)

82,947,711

Total (%)

8.62

Date of Notice

19-Nov-2024

Market Buzz

2024-11-21

EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) acquired 45,700 shares on 18-Nov-2024.

2024-11-20

No More Pharmaceutical Procurement Through Just One Company — Health Minister

2024-11-19

EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) acquired 82,000 shares on 14-Nov-2024.

2024-11-15

EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) acquired 450,000 shares on 12-Nov-2024.

2024-11-15

Price Target

Duopharma Biotech - Missing the Spark
Source : RHB-OSK, Price Call : HOLD, Price Target : 1.34
Last Price : 1.25, Upside/Downside : +0.09(7.20%)

2024-11-13

EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) acquired 77,500 shares on 08-Nov-2024.

2024-11-12

EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) acquired 400,000 shares on 07-Nov-2024.

2024-11-11

Daily Market Commentary - 11 Nov 2024

2024-11-11

Daily Market Report - 11 Nov 2024

2024-11-11

Mplus Market Pulse - 11 Nov 2024

2024-11-11

EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) acquired 703,000 shares on 06-Nov-2024.

2024-11-11

Price Target

Duopharma Biotech Berhad - Solid 3Q24 Performance
Source : TA, Price Call : BUY, Price Target : 1.50
Last Price : 1.25, Upside/Downside : +0.25(20.00%)

2024-11-11

Price Target

Duopharma Biotech - Results in Line
Source : RHB-OSK, Price Call : HOLD, Price Target : 1.34
Last Price : 1.25, Upside/Downside : +0.09(7.20%)

Discussions

Be the first to like this. Showing 0 of 0 comments

Post a Comment

Featured Posts

MQ Trader

Introducing MY's First IPO Fund for Sophisticated Investors!

MQ Chat

New Update. Discover investment communities that resonate with your ideas

MQ Trader

M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a

Latest Videos

New IPO: A fertilizer formulating and blending company, Cropmate Berhad aims to list on the ACE Market!

0:17

New IPO: A fertilizer formulating and blending company, Cropmate Berhad aims to list on the ACE Market!

MQ Trader 52 views | 5 h ago

New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!

0:17

New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!

MQ Trader 954 views | 14 d ago

M & A Value Partners IPO Equity Fund

0:43

M & A Value Partners IPO Equity Fund

MQ Trader 10494 views | 4 mo ago

MQ Market Updates - 21 November 2024

0:16

MQ Market Updates - 21 November 2024

MQ Trader 44 views | 4 h ago

MQ Market Updates - 20 November 2024

0:15

MQ Market Updates - 20 November 2024

MQ Trader 120 views | 1 d ago

MQ Trading Signals

2024-11-21 16:35:00

ADX

5 Mins

SELL

2024-11-21 16:30:00

ADX

10 Mins

BUY

2024-11-21 16:30:00

EMA 5

5 Mins

BUY

2024-11-21 16:30:00

ADX

5 Mins

BUY

2024-11-21 15:00:00

EMA 5

5 Mins

SELL

More Trading Signals

Apps

Send individual or group chats with anyone on i3investor

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

Online learning and teaching marketplace

Top Articles

1

save malaysia!

Hypocrisy of branding DAP communists yet PAS, Bersatu leaders make beeline to China for official visit

2

save malaysia!

“The one eatery with giant Chinese signage that gives you China feel serves forbidden meat, Tun M”

3

Good Articles to Share

A 30-Year Expert Trader’s HONEST Confession - Ziet Invests

4

Koon Yew Yin's Blog

Why all plantation companies will continue to report more profit - Koon Yew Yin

5

AmInvest Research Reports

Power - Valuations are no longer compelling

6

save malaysia!

Malaysia could lose RM100b in palm oil exports value without licensing for planting

7

save malaysia!

The tale of Innov8tif and five public-listed companies

8

save malaysia!

Malaysia vows affordable medical protection plans as population ages

Hot Stocks Today >

1

YTL POWER INTERNATIONAL BHD

1000

2

YTL CORPORATION BHD

796

3

MALAYAN BANKING BHD

770

4

PETRONAS CHEMICALS GROUP BHD

670

5

MY E.G. SERVICES BHD

636

6

CAPITAL A BERHAD

429

7

DIALOG GROUP BHD

398

8

TOP GLOVE CORPORATION BHD

369

9

GENTING BHD

353

10

SAPURA ENERGY BERHAD

342

Daily Stocks

0.91

+0.03

98,043,100

1.05

-0.04

53,500,500

0.285

0.00

39,048,400

0.14

-0.005

31,142,100

1.83

-0.13

30,452,400

0.37

+0.01

29,927,900

2.98

-0.17

27,461,900

0.04

0.00

26,624,900

0.32

+0.045

24,368,900

0.11

+0.02

23,907,800

More active Stocks

4.83

+0.26

18,448,200

7.65

+0.12

819,000

20.14

+0.12

55,700

1.50

+0.11

25,200

5.66

+0.11

4,600

2.20

+0.09

1,000

10.20

+0.08

8,807,300

3.65

+0.08

1,117,500

13.28

+0.08

29,900

4.97

+0.07

13,554,500

More gainer Stocks

24.36

-0.52

295,500

13.80

-0.50

8,339,900

13.78

-0.48

42,400

17.58

-0.42

383,900

10.54

-0.40

3,200

13.50

-0.30

716,900

6.61

-0.23

1,225,800

8.87

-0.21

5,959,300

97.80

-0.20

107,600

3.15

-0.18

765,500

More loser Stocks

Featured Advertisers / Partners

Top Brokers >

1

2

TA

3

Affin Hwang

4

Rakuten Trade

5

Hong Leong Bank

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....